• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ACON LABORATORIES, INC. FLOWFLEX ANTIGEN HOME TEST; OVER-THE-COUNTER COVID-19 ANTIGEN TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ACON LABORATORIES, INC. FLOWFLEX ANTIGEN HOME TEST; OVER-THE-COUNTER COVID-19 ANTIGEN TEST Back to Search Results
Lot Number COV3030009
Patient Problem Unspecified Infection (1930)
Event Date 02/13/2024
Event Type  Injury  
Event Description
I took a flowflex antigen home test.It was positive.I went to the urgent care and got a pcr (polymerase chain reaction) rvs.Both were negative.They asked me to do another at home and i did and it was positive.I did another pcr on wed.Neg.Thurs.Binaxnow neg.Friday binaxnow neg.I'm so glad i did not take the paxlovid.I have a bacterial infection.My boxes of flowflex say expire 2025, date (2) (b)(6), one (b)(6) on 1.Your website says 2024 for cov3030007 ov3030007 expire this month.This was a false positive i believe because the close expiration date being 2024 not 2025.Reference # mw5151805.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLOWFLEX ANTIGEN HOME TEST
Type of Device
OVER-THE-COUNTER COVID-19 ANTIGEN TEST
Manufacturer (Section D)
ACON LABORATORIES, INC.
MDR Report Key18758704
MDR Text Key336049860
Report NumberMW5151804
Device Sequence Number1
Product Code QYT
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 02/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Lot NumberCOV3030009
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/21/2024
Patient Sequence Number1
Treatment
AMLODIPINE.; BINAXNOW COVID TEST.; CALCIUM .; COQ10 .; LIPITOR "MYBECK".; MAGNESIUM.; POTASSIUM .; RESTASIS.; VITAMIN C .; VITAMIN D2.
Patient Outcome(s) Other;
Patient Age83 YR
Patient SexFemale
Patient Weight77 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-